(Q34594877)

3 August 2017

title

Marginal increase of sunitinib exposure by grapefruit juice (English)

1 reference

3 August 2017

9

Henk-Jan Guchelaar

1 reference

3 August 2017

10

Hans Gelderblom

1 reference

3 August 2017

2

Sharyn D Baker

1 reference

3 August 2017

1

Nielka P van Erp

1 reference

3 August 2017

4

Bart A Ploeger

1 reference

3 August 2017

7

Jan den Hartigh

1 reference

3 August 2017

Anthe S Zandvliet

3

1 reference

3 August 2017

Margaret den Hollander

series ordinal

5

1 reference

3 August 2017

Zhaoyuan Chen

series ordinal

6

1 reference

3 August 2017

Jacqueline M C König-Quartel

series ordinal

8

1 reference

3 August 2017

publication date

29 May 2010

1 reference

Cancer Chemotherapy and Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

67

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

695-703

1 reference

Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Influence of solute carriers on the pharmacokinetics of CYP3A4 probes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Diagnosing model diagnostics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Intestinal drug transporter expression and the impact of grapefruit juice in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Grapefruit-drug interactions: can interactions with drugs be avoided?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies

7 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

7 July 2018

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Effect of grapefruit juice intake on etoposide bioavailability

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Inhibition of P-glycoprotein transport function by grapefruit juice psoralen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Grapefruit juice-drug interactions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects

7 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Assessment of actual significance levels for covariate effects in NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Interaction between grapefruit juice and midazolam in humans*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1367-0

Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043256

Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20512335

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00280-010-1367-0

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference